Please login to the form below
UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
MHRA approved the drug under the Early Access to Medicines Scheme
Merck buys Themis as part of drive for COVID-19 drugs and vaccines
Deal also adds a pipeline of vaccines for other infectious diseases as well as cancer
FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC
Finally wins approval in market dominated by rival Keytruda
New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell
Remdesivir could speed recovery of patients with COVID-19, but hydroxychloroquine may not be safe
CEPI-backed coronavirus vaccine from Novavax starts trials
NVX-CoV2373 is tenth vaccine to reach human testing stage
NICE approves Roche’s Tecentriq in TNBC after revising deal
Discounted price deal sees immunotherapy recommended for use
AZ secures capacity for one billion coronavirus vaccine doses
Initial agreement to supply 400 million doses of Oxford University’s vaccine
EMA starts review of MorphoSys’ tafasitamab for lymphoma
Drug could challenge Novartis and Gilead’s CAR-T therapies if approved
Gilead, Galapagos dip on mixed ulcerative colitis data
Drug may not work well enough to displace rivals
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
Roche makes protein degradation play with $135m Vividion dealExclusive deal with Vividion includes potential for “multibillion dollar future payments”
-
Octapharma cleared to start phase 3 trial of Octagam in COVID-19Drug may stop or slow down deterioration in seriously ill patients
-
UK government expands coronavirus testing criteriaThose aged five and over will now be eligible for testing
-
FDA gives Roche’s Tecentriq green light for first-line NSCLC
Company enters lucrative and competitive market dominated by Merck/MSD’s rival Keytruda
-
Trailing Clovis, AstraZeneca gets FDA approval for Lynparza in prostate cancerPhase 3 PROfound trial showed drug cut the risk of disease progression or death by 66%
-
Moderna’s coronavirus vaccine hits first objectivesStudy shows vaccine stimulated COVID-19 antibodies in healthy volunteers
-
Novartis claims EU approval for SMA gene therapy ZolgensmaCompany in discussion with EU countries over pricing in the hope of launching it quickly
-
Ex-BMS exec jumps to Gilead to lead research group Gilead appoints Michael Quigley to lead research team
-
New hires at Crescendo, Healx and Galecto The latest movers in pharma
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directorsHorning retired from Roche last August
-
F-star hires ex-BMS immuno-oncology leader
New CMO to oversee development of lead candidate
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
Latest research appointments
COVID-19 Updates and Daily News
Featured jobs
- Regeneron says antibody for COVID-19 could be ready this year
- Octapharma cleared to start phase 3 trial of Octagam in COVID-19
- UK’s new COVID-19 trial initiative fast-tracks BerGenBio’s bemcentinib
- NHS England will make PrEP for HIV available in April
- Gilead, Galapagos dip on mixed ulcerative colitis data
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- Oxford University Press advertising and custom content team hosts their first ever virtual drop-in sessions
- UK clears NHS use of Gilead’s remdesivir for COVID-19 patients
- Merck buys Themis as part of drive for COVID-19 drugs and vaccines
- FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC
- Now is the time to show just how valuable this industry is to the UK
- COVID-19: the race to find a vaccine
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- COVID-19: the race to find a vaccine
- How biopharma is working to bring an end to the pandemic...
- Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
- Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...
- ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
- The art of delivering valuable customer journeys aligned to your key messages in 2020...
Quick links
Infographics
